Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells.

Myasthenia gravis (MG) is an antibody-mediated autoimmune disorder where the neuromuscular transmission is impaired, causing symptoms of skeletal muscle weakness and fatigue.

Robotic resection of thymoma recurrence with intra thoracic phrenic nerve reconstruction using a sural nerve graft: a case report

This study aims to demonstrate the feasibility of nerve reconstruction using a sural nerve graft by total robotic approach which has never been reported before.

Case Report: Robotic-assisted removal of a large thymoma

We present a relatively common case of a substantial anterior mediastinal mass with a high suspicion of thymoma.

Risk factors for pleural recurrence in thymic epithelial tumors: a scoping review

This review aims to identify and discuss the predictors associated with pleural metastases in patients with TET.

The DETECTION study part 1: an international Delphi survey about diagnostics and treatment of anterior mediastinal cysts Lung Cancer

The first part of the DETECTION project focuses on possible heterogeneity in diagnostics and treatment of anterior mediastinal cystic lesions among international thoracic medical experts.

Outcomes after robotic thymectomy in nonthymomatous versus thymomatous patients with acetylcholine-receptor-antibody-associated myasthenia gravis

The aim of this study was to investigate the surgical and long-term neurological outcomes of patients with acetylcholine-receptor-antibody-associated myasthenia gravis (AChR-MG) who underwent robotic thymectomy (RATS).

Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis

A meta-analysis to better evaluate the existing evidence about the activity and safety of ICB in the setting of unresectable or metastatic advanced TET previously treated with platinum-based chemotherapy.

Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders

This review presents established therapies as well as novel therapeutic approaches for MG and related conditions, with a focus on AChR-MG.

Radiotherapy for Thymic Epithelial Tumors: What Is The Optimal Dose? A Systematic Review

This overview can spark new evidence to define the optimal RT dose for each TETs category.

The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis

The aim of this study was to analyse a possible association between anti-AChR-ab serum levels and clinical improvement of MG.